Product information
From Health Canada
No match found
No other product was found from this company.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2024-10-29
Original market date: See footnote 1
2012-02-24
Product name:
FAMPYRA
DIN:
02379910
Product Monograph/Veterinary Labelling:
Date:
2024-10-29
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ACORDA THERAPEUTICS IRELAND LIMITED
10 Earlsfort Terrace
Dublin 2
--
Ireland
D02 T38
Class:
Human
Dosage form(s):
Tablet (Extended-Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
92:56.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
N07XX07 FAMPRIDINE
Active ingredient group (AIG) number:See footnote5
0153090001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| FAMPRIDINE | 10 MG |
Risk Management Plans See footnote 7
A Risk Management Plan (RMP) for this product was submitted.